Guide to Humatrope Dosing

About This Tool

The Humatrope Dose Calculator is a clinical support tool designed to help healthcare professionals determine the appropriate volume of reconstituted Humatrope to administer based on patient-specific parameters and the prescribed dosing regimen. It simplifies the conversion from a weight-based dose (e.g., mg/kg/week) to a precise injection volume (mL) for daily administration.

Understanding the Outputs

After entering the required information, the calculator provides the following key outputs:

• Total Dose per Week (mg/week): The total amount of somatropin the patient will receive over a seven-day period.
• Total Dose per Day (mg/day): The daily dosage, typically calculated by dividing the weekly dose by seven.
• Volume to Administer per Injection (mL): The final, crucial output. This is the volume of reconstituted solution that should be drawn up and administered for each daily injection to deliver the prescribed dose.

How to Use the Calculator

To ensure accurate results, follow these steps:

1. Select the Indication for Use: Choose the specific FDA-approved indication, as dosing recommendations vary significantly between conditions like Pediatric GHD, Turner Syndrome, or Adult Onset GHD.
2. Enter Patient Weight: Input the patient's current weight. You can use kilograms (kg) or pounds (lbs); the tool will convert as needed.
3. Enter Patient Height (if required): For Idiopathic Short Stature (ISS), height is a necessary parameter. Use centimeters (cm) or inches (in).
4. Input the Prescribed Dose: For pediatric patients, enter the weight-based dose in either mg/kg/week or mg/kg/day. For adults, enter the prescribed starting dose in mg/day.
5. Configure the Product: Select the Humatrope cartridge or vial size (e.g., 5 mg, 12 mg) and the corresponding diluent volume used for reconstitution. The tool will automatically calculate the final drug concentration (mg/mL).

Dosing Overview

Humatrope dosing is highly individualized and depends on the indication, age, and clinical response of the patient.

• Pediatric Dosing: Generally weight-based and expressed as mg/kg/week. The total weekly dose is typically divided into 6 or 7 equal subcutaneous injections.
• Adult Dosing: Can be weight-based or non-weight-based. The calculator uses the non-weight-based approach, starting with a low dose (e.g., 0.2 mg/day) and titrating upwards based on clinical response and serum IGF-I concentrations.

Doses should be adjusted according to individual patient response and monitoring of growth parameters, pubertal status, and serum IGF-I levels.

Switching Between Growth Hormone Products

There are multiple recombinant human growth hormone products available. While all contain somatropin, they are not considered bioequivalent and should not be interchanged without the guidance of a healthcare professional. If switching a patient to Humatrope from another product, re-evaluation of the appropriate dose by an endocrinologist is essential.

Handling a Missed Dose

If a dose of Humatrope is missed, the patient or caregiver should be advised to administer the next dose at the regularly scheduled time. They should not double the dose to make up for the missed one. Consistent daily administration is important for optimal efficacy. If questions arise, the prescribing physician should be contacted.

Safety Alerts

This calculator is not a substitute for clinical judgment. Dosing must be guided by the official Humatrope Prescribing Information. Pay close attention to contraindications, warnings, and precautions, including monitoring for glucose intolerance, intracranial hypertension, and fluid retention, especially in adult patients. The goal in adults is to use the lowest effective dose, titrated based on clinical and biochemical (IGF-I) response.

Frequently Asked Questions

Why is patient height required for the Idiopathic Short Stature (ISS) indication?

The diagnosis of ISS requires meeting specific criteria related to height standard deviation score (SDS). While the dose is weight-based, confirming height is a crucial part of ensuring the patient is an appropriate candidate for treatment under this indication as per FDA guidelines.

What is the difference between mg/kg/week and mg/kg/day dosing units?

The Prescribing Information typically specifies dosing ranges in mg/kg/week. However, some clinical workflows may use a daily weight-based dose. The tool accommodates both, converting a daily dose to a weekly equivalent (by multiplying by 7) to perform the final calculation.

How is the final concentration determined?

The final concentration (in mg/mL) is a simple calculation: the total amount of drug in the vial (mg) divided by the volume of diluent added (mL). For example, a 5 mg vial reconstituted with 2.5 mL of diluent yields a final concentration of 2.0 mg/mL.

Can I use this calculator for other brands of somatropin?

No. This tool is specifically designed for Humatrope. Other somatropin products may come in different vial/cartridge sizes and use different diluents, resulting in different final concentrations. Always use tools and guidance specific to the prescribed brand.

Why does the adult dosing section ask for a fixed mg/day dose?

For adult GHD, treatment is often initiated with a low, non-weight-based dose (e.g., 0.2 mg/day) and then titrated every 1-2 months based on the patient's clinical response and serum IGF-I levels. This contrasts with the initial weight-based approach common in pediatrics.

What happens if I enter a dose outside the standard range?

The calculator will still compute the volume for the entered dose but will display a warning message. This serves as a clinical decision support alert, prompting you to verify that the out-of-range dose is intentional and clinically justified.

Does the tool account for dose titration over time?

No, the calculator provides a point-in-time calculation based on the currently prescribed dose. As the dose is titrated up or down based on clinical response, the new dose must be re-entered into the calculator to determine the new injection volume.

Where does the list of vial sizes and diluent volumes come from?

The options in the calculator are based on the available presentations of Humatrope as detailed in the official U.S. Prescribing Information. This includes the 5 mg vial (which can be reconstituted with various diluent volumes) and the cartridges for use with pen devices.

References

• Humatrope (somatropin) for injection, Prescribing Information. U.S. Food and Drug Administration. Eli Lilly and Company. Revised: 01/2015.
• Humatrope Official Healthcare Professional Website. Eli Lilly and Company.
• Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr. 2016;86(6):361-397.
• Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609.